rs184536370

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015922.3(NSDHL):​c.267+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000685 in 1,208,037 control chromosomes in the GnomAD database, including 3 homozygotes. There are 281 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00084 ( 0 hom., 41 hem., cov: 23)
Exomes 𝑓: 0.00067 ( 3 hom. 240 hem. )

Consequence

NSDHL
NM_015922.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0001858
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.835

Publications

0 publications found
Variant links:
Genes affected
NSDHL (HGNC:13398): (NAD(P) dependent steroid dehydrogenase-like) The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
NSDHL Gene-Disease associations (from GenCC):
  • CHILD syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • CK syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-152850430-G-A is Benign according to our data. Variant chrX-152850430-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 211749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000837 (94/112358) while in subpopulation NFE AF = 0.000957 (51/53282). AF 95% confidence interval is 0.000748. There are 0 homozygotes in GnomAd4. There are 41 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 41 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSDHLNM_015922.3 linkc.267+7G>A splice_region_variant, intron_variant Intron 3 of 7 ENST00000370274.8 NP_057006.1 Q15738A0A384NPZ7
NSDHLNM_001129765.2 linkc.267+7G>A splice_region_variant, intron_variant Intron 4 of 8 NP_001123237.1 Q15738A0A384NPZ7
NSDHLNM_001441099.1 linkc.267+7G>A splice_region_variant, intron_variant Intron 5 of 9 NP_001428028.1
NSDHLXM_017029564.2 linkc.315+7G>A splice_region_variant, intron_variant Intron 3 of 7 XP_016885053.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSDHLENST00000370274.8 linkc.267+7G>A splice_region_variant, intron_variant Intron 3 of 7 1 NM_015922.3 ENSP00000359297.3 Q15738
NSDHLENST00000440023.5 linkc.267+7G>A splice_region_variant, intron_variant Intron 4 of 8 5 ENSP00000391854.1 Q15738
NSDHLENST00000432467.1 linkc.267+7G>A splice_region_variant, intron_variant Intron 4 of 7 3 ENSP00000396266.1 C9JDR0

Frequencies

GnomAD3 genomes
AF:
0.000837
AC:
94
AN:
112303
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000566
Gnomad ASJ
AF:
0.00188
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00506
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000957
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00140
AC:
257
AN:
183209
AF XY:
0.00118
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000766
Gnomad ASJ exome
AF:
0.00241
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00762
Gnomad NFE exome
AF:
0.00111
Gnomad OTH exome
AF:
0.00110
GnomAD4 exome
AF:
0.000669
AC:
733
AN:
1095679
Hom.:
3
Cov.:
31
AF XY:
0.000665
AC XY:
240
AN XY:
361075
show subpopulations
African (AFR)
AF:
0.0000759
AC:
2
AN:
26356
American (AMR)
AF:
0.000625
AC:
22
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00191
AC:
37
AN:
19368
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30199
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54066
European-Finnish (FIN)
AF:
0.00666
AC:
270
AN:
40532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4073
European-Non Finnish (NFE)
AF:
0.000438
AC:
368
AN:
839863
Other (OTH)
AF:
0.000739
AC:
34
AN:
46016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000837
AC:
94
AN:
112358
Hom.:
0
Cov.:
23
AF XY:
0.00119
AC XY:
41
AN XY:
34516
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30977
American (AMR)
AF:
0.000566
AC:
6
AN:
10608
Ashkenazi Jewish (ASJ)
AF:
0.00188
AC:
5
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3591
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2681
European-Finnish (FIN)
AF:
0.00506
AC:
31
AN:
6124
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000957
AC:
51
AN:
53282
Other (OTH)
AF:
0.00
AC:
0
AN:
1538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00167
Hom.:
15
Bravo
AF:
0.000461
EpiCase
AF:
0.000382
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 28, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Benign:1
Nov 13, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.3
DANN
Benign
0.56
PhyloP100
0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs184536370; hg19: chrX-152018974; API